Allergic Contact Dermatitis in Atopic Dermatitis: Overlap, Common Allergens, Patch Testing, and Management

Conclusions

• Atopic dermatitis does not protect against allergic contact dermatitis and may actually increase the risk because of skin-barrier dysfunction, increased product exposure, and chronic inflammation.
• A substantial fraction of patients with atopic dermatitis referred for patch testing have clinically relevant contact allergies, so coexistence of the two conditions is common.
• Fragrances, surfactants such as cocamidopropyl betaine and related cross-reactors, isothiazolinones, formaldehyde releasers, topical antibiotics, lanolin, and acrylates are especially important allergens to consider in this population.
• Head/neck, eyelid, and hand dermatitis, or dermatitis that changes pattern, worsens despite treatment, or appears atypical, should raise strong suspicion for superimposed allergic contact dermatitis.
• Patch testing should generally use broad screening panels plus supplemental and patient-product testing, because personal care products and prescribed topicals are frequent hidden sources of allergens.
• Patients need careful preparation for patch testing, including clear test sites and temporary adjustment of topical, systemic, and biologic therapies when feasible to reduce false results.
• Positive patch tests must be interpreted for clinical relevance using product review and follow-up, because not every positive reaction explains the dermatitis.
• Management should focus first on strict topical/cutaneous avoidance of relevant allergens, cross-reactors, and irritants for about three months before judging success.
• Systemic dietary avoidance is not routinely recommended and should be considered only selectively and case by case.
• Using safe lists and simpler hyporeactive products can reduce patient burden and improve adherence to allergen avoidance.
• If dermatitis improves with avoidance, allergen avoidance should continue; if not, treatment should pivot back toward optimizing atopic dermatitis therapy.
• Overall, the best outcomes come from matching the distribution and history to likely allergens, testing broadly, and then treating the patient based on objective improvement rather than patch test results alone.